Active Ingredient(s):Trastuzumab + Hyaluronidase-oysk FDA Approved: * February 28, 2019 Pharm Company: *GENENTECH INC Category:Cancer
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.&am...
* May have multiple approval dates, manufacturers, or labelers.